During the past decade, BCCA - Cancer Centre for the Southern Interior conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 41 clinical trials were completed, i.e. on average, 105.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 15 clinical trials were completed. i.e. 115.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BCCA - Cancer Centre for the Southern Interior" #1 sponsor was "NCIC Clinical Trials Group" with 30 trials, followed by "British Columbia Cancer Agency" with 19 trials sponsored, "Canadian Cancer Trials Group" with 16 trials sponsored, "Hoffmann-La Roche" with 12 trials sponsored and "Radiation Therapy Oncology Group" with 12 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BCCA - Cancer Centre for the Southern Interior" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 13 trials as a collaborator, "AstraZeneca" with 9 trials as a collaborator and "Cancer and Leukemia Group B" with 9 trials as a collaborator. Other collaborators include 132 different institutions and companies that were collaborators in the rest 90 trials.

According to Clinical.Site data, the most researched conditions in "BCCA - Cancer Centre for the Southern Interior" are "Prostate Cancer" (28 trials), "Breast Cancer" (21 trials), "Ovarian Cancer" (8 trials), "Colorectal Cancer" (7 trials) and "Fallopian Tube Cancer" (5 trials). Many other conditions were trialed in "BCCA - Cancer Centre for the Southern Interior" in a lesser frequency.

Most popular intervention types in "BCCA - Cancer Centre for the Southern Interior" are "Drug" (108 trials), "Radiation" (30 trials), "Other" (29 trials), "Procedure" (15 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Docetaxel" (7 trials), "Durvalumab" (6 trials), "placebo" (6 trials) and "Atezolizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "BCCA - Cancer Centre for the Southern Interior" are 69 trials for "All" genders, 37 trials for "Female" genders and 36 trials for "Male" genders.

Currently, there are NaN active trials in "BCCA - Cancer Centre for the Southern Interior". 1 are not yet recruiting, 21 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 85 completed trials in BCCA - Cancer Centre for the Southern Interior, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in BCCA - Cancer Centre for the Southern Interior, 10 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".